Raymond James Reiterates Outperform Rating on Agios Pharma (AGIO)

October 31, 2024 1:16 PM EDT Send to a Friend
Raymond James analyst Danielle Brill reiterated an Outperform rating and $51.00 price target on Agios Pharma (NASDAQ: AGIO)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login